E. Kayıkçıoglu and E. Findos, “The prognostic immune nutritional index is a predictive biomarker in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide: Prognostic immune nutritional index and prostate adenocancer”, The Injector , vol. 1, no. 3, pp. 106–114, Nov. 2022.